Headlines about Camden National (NASDAQ:CAC) have trended somewhat positive this week, Accern Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Camden National earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 45.1494165910804 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Camden National (NASDAQ CAC) traded down $0.21 during trading hours on Friday, hitting $45.48. The company had a trading volume of 48,199 shares, compared to its average volume of 29,903. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $705.67, a P/E ratio of 16.72 and a beta of 0.79. Camden National has a 12 month low of $37.10 and a 12 month high of $47.41.
A number of equities research analysts recently commented on the company. Keefe, Bruyette & Woods downgraded Camden National from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 1st. BidaskClub downgraded Camden National from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th.
Camden National Company Profile
Camden National Corporation is a bank holding company. The Company is a diversified financial services provider. The primary business of the Company and its subsidiary, Camden National Bank (the Bank), is to attract deposits from, and to extend loans to, consumer, institutional, municipal, non-profit and commercial customers.
What are top analysts saying about Camden National Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Camden National Corporation and related companies.